GlassScriptPhysician profile
Igor Rubinshteyn
NPI 1235292574
$3,474.04
in general payments reported to CMS, 2019-2025
20 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $215 · 2021: $846 · 2022: $428 · 2023: $184 · 2024: $1,214 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973 · Travel and Lodging: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.47 |
| Travel and Lodging | $710.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $853.10 | 2023-2024 | Iovera, Exparel, Zilretta |
| Fidia Pharma USA INC. | $717.70 | 2019-2025 | Triluron, Hymovis |
| Orthofix Medical, INC. | $649.24 | 2021-2025 | Physio-Stim |
| Sanara Medtech INC. | $224.83 | 2024 | Celleraterx |
| Horizon Therapeutics Plc | $177.99 | 2019-2021 | |
| Pacira Therapeutics, INC. | $146.02 | 2020-2021 | |
| Emd Serono, INC. | $124.93 | 2019 | |
| Zimmer Biomet Holdings, INC. | $98.91 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $88.99 | 2025 | |
| Depuy Synthes Sales INC. | $87.63 | 2023-2024 | Orthovisc |
| Amgen INC. | $62.25 | 2019-2025 | Evenity, Prolia, Prolia |
| Djo, LLC | $43.39 | 2025 | Cmf |
| Astellas Pharma US INC | $41.98 | 2019 | |
| Orthogenrx INC. | $37.30 | 2019-2020 | |
| Si-Bone, INC. | $27.04 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.22 | 2019 | |
| Axogen | $22.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.87 | 2019 | |
| Stryker Corporation | $13.34 | 2024 | Gamma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Rubinshteyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.